"name","label","text","uuid:ID","instanceType","description","id"
"OBJ1","","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","167ca3a8-e9e4-485f-a3a6-bd5036e00444","Objective","Main objective","Objective_1"
"OBJ2","","To document the safety profile of the xanomeline TTS.","1f7ce19b-f893-4845-a2ae-9ef8c64f5564","Objective","Safety","Objective_2"
"OBJ3","","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","79ba6582-6bdf-4baf-a566-7cb2d3136615","Objective","Behaviour","Objective_3"
